The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma.

Hajek, Roman; Siegel, David; Orlowski, Robert Z; Ludwig, Heinz; Palumbo, Antonio; Dimopoulos, Meletios

Hajek, Roman; Siegel, David; Orlowski, Robert Z; Ludwig, Heinz; Palumbo, Antonio; Dimopoulos, Meletios.

Affiliation

Hajek R; Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.

Leuk Lymphoma ; 55(1): 11-8, 2014 Jan.

Article in En | MEDLINE | ID: mdl-23614765

Subject(s)

Histone Deacetylase Inhibitors/therapeutic use; Multiple Myeloma/drug therapy; Multiple Myeloma/mortality; Animals; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Drug Evaluation, Preclinical; Humans; Neoplasm Recurrence, Local; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Histone Deacetylase Inhibitors / Multiple Myeloma Language: En Journal: Leuk Lymphoma Year: 2014 Type: Article Affiliation country: Czech Republic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google